These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Almitrine bismesylate and ventilation-perfusion ratios]. Evrard Y Rev Mal Respir; 1985; 2 Suppl 1():S17-22. PubMed ID: 2870542 [TBL] [Abstract][Full Text] [Related]
9. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease. Saadjian AY; Philip-Jöel FF; Barret A; Levy S; Arnaud AG Eur Respir J; 1994 May; 7(5):862-8. PubMed ID: 8050541 [TBL] [Abstract][Full Text] [Related]
10. Action of almitrine bismesylate on ventilation-perfusion matching in cats and dogs with part of the lung hypoventilated. Wach RA; Gill GW; Suggett AJ; Bee D; Barer G Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):453-67. PubMed ID: 3757310 [TBL] [Abstract][Full Text] [Related]
11. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)]. Castaing Y; Manier G; Varène N; Guénard H Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629 [TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD. Melot C; Naeije R; Hallemans R; Mols P; Lejeune P Eur J Respir Dis Suppl; 1983; 126():249-54. PubMed ID: 6586439 [TBL] [Abstract][Full Text] [Related]
13. Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Reyes A; Roca J; Rodriguez-Roisin R; Torres A; Ussetti P; Wagner PD Am Rev Respir Dis; 1988 May; 137(5):1062-7. PubMed ID: 3195804 [TBL] [Abstract][Full Text] [Related]